Leukemia and Lymphoma

August 2nd 2020

In a busy week, FDA approved ground-breaking therapies in hematologic cancers and issued Orphan Drug designations in areas of significant unmet need.

July 25th 2019

How a tool is helping execs define and measure value in oncology.

July 14th 2019

Top oncology experts share how they deliver these therapies to patients in need.

May 1st 2019

With so many new immunotherapy treatments on the horizon, pharmacists need to understand the ins and outs of immuno-oncology biomarkers to best serve their patients.